Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 40

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 40
---
ation, or other violation could prevent us from commercializing our products or force us to cease some of our operations, which
could materially harm our business. Claims that Renovaro Cube or BioSymetrics has misappropriated the confidential information or trade
secrets of third parties could have a similar negative impact on our business.

40

Even
if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant
expenses and could distract our personnel from their normal responsibilities. Such litigation or proceedings could substantially increase
our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities.
We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors
may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources
and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent
litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.

Renovaro
Cube’s and BioSymetrics’ use of open-source software could subject our proprietary technology to unwanted open-source license
conditions that could negatively impact its business.

A portion
of our technology capabilities incorporates open-source software, and we may incorporate open-source software into
other offerings or products in the future. If an author or other third party that distributed such open-source software to Renovaro
Cube or BioSymetrics were to allege that we had not complied with the conditions of one or more of these licenses, we could be required
to incur significant legal expenses defending against such allegations. Further, the outcome of such litigation may be particularly uncertain
in some cases, because there is little legal precedent governing the interpretation of certain terms of common open-source licenses. In
addition, if Renovaro Cube or BioSymetrics combines its proprietary software with open-source software in a certain manner and
makes it available to others, under some open-source licenses, it could be required to license or make available the source
code of its proprietary software, which could substantially help its competitors develop products that are similar to or better than ours
and harm our business.

The
success and growth of Renovaro Cube’s or BioSymetrics’ business depends upon their ability to continuously innovate and develop
new products and technologies.

Renovaro
Cube’s and BioSymetrics